Drugs / [18F]MNI-1126
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03587649 | May 2018 → Feb 2020 | Alzheimer disease, Parkinson disease | Invicro | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]MNI-1126 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03587649 ↗ |